pH-dependent Internalization of Muramyl Peptides from Early Endosomes Enables Nod1 and Nod2 Signaling*

Nod1 and Nod2 are members of the Nod-like receptor family that detect intracellular bacterial peptidoglycan-derived muramyl peptides. The biological effects of muramyl peptides have been described for over three decades, but the mechanism underlying their internalization to the cytosol remains unclear. Using the human epithelial cell line HEK293T as a model system, we demonstrate here that Nod1-activating ligands entered cells through endocytosis, most likely by the clathrin-coated pit pathway, as internalization was dynamin-dependent but not inhibited by methyl-β-cyclodextrin. In the endocytic pathway, the cytosolic internalization of Nod1 ligands was pH-dependent, occurred prior to the acidification mediated by the vacuolar ATPase, and was optimal at pH ranging from 5.5 to 6. Similarly, the Nod2 ligand MDP was internalized into host cytosol through a similar pathway with optimal pH for internalization ranging from 5.5 to 6.5. Moreover, Nod1-activating muramyl peptides likely required processing by endosomal enzymes, prior to transport into the cytosol, suggesting the existence of a sterically gated endosomal transporter for Nod1 ligands. In support for this, we identified a role for SLC15A4, an oligopeptide transporter expressed in early endosomes, in Nod1-dependent NF-κB signaling. Interestingly, SLC15A4 expression was also up-regulated in colonic biopsies from patients with inflammatory bowel disease, a disorder associated with mutations in Nod1 and Nod2. Together, our results shed light on the mechanisms by which muramyl peptides get access to the host cytosol, where they are detected by Nod1 and Nod2, and might have implications for the understanding of human diseases, such as inflammatory bowel disease.

[1]  G. Núñez,et al.  Clathrin- and Dynamin-Dependent Endocytic Pathway Regulates Muramyl Dipeptide Internalization and NOD2 Activation1 , 2009, The Journal of Immunology.

[2]  Praveen M. Bahadduri,et al.  Bacterial peptide recognition and immune activation facilitated by human peptide transporter PEPT2. , 2008, American journal of respiratory cell and molecular biology.

[3]  D. Philpott,et al.  The microbial and danger signals that activate Nod-like receptors. , 2008, Cytokine.

[4]  S. Akira,et al.  TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β , 2008, Nature Immunology.

[5]  S. Girardin,et al.  Nod1 and Nod2 in innate immunity and human inflammatory disorders. , 2007, Biochemical Society transactions.

[6]  S. Grinstein,et al.  Phagosomal acidification: measurement, manipulation and functional consequences. , 2007, Biochemical Society transactions.

[7]  D. Portnoy,et al.  Bacterial Ligands Generated in a Phagosome Are Targets of the Cytosolic Innate Immune System , 2007, PLoS pathogens.

[8]  D. Philpott,et al.  Nod-like proteins in immunity, inflammation and disease , 2006, Nature Immunology.

[9]  M. Brandsch,et al.  The renal type H+/peptide symporter PEPT2: structure-affinity relationships , 2006, Amino Acids.

[10]  M. Kaksonen,et al.  Harnessing actin dynamics for clathrin-mediated endocytosis , 2006, Nature Reviews Molecular Cell Biology.

[11]  T. Kirchhausen,et al.  Dynasore, a cell-permeable inhibitor of dynamin. , 2006, Developmental cell.

[12]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[13]  E. Latz,et al.  Endocytic pathways regulate Toll‐like receptor 4 signaling and link innate and adaptive immunity , 2006, The EMBO journal.

[14]  J. Bertin,et al.  Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin , 2005, EMBO reports.

[15]  D. Russell,et al.  Phagosome maturation proceeds independently of stimulation of toll-like receptors 2 and 4. , 2005, Immunity.

[16]  R. Xavier,et al.  Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor–κB activation in muramyl dipeptide recognition , 2005, The Journal of cell biology.

[17]  Y. Nakagawa,et al.  hPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonic Caco2/bbe cells. , 2004, Gastroenterology.

[18]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[19]  R. Medzhitov,et al.  Regulation of Phagosome Maturation by Signals from Toll-Like Receptors , 2004, Science.

[20]  T. Hartung,et al.  Structural Requirements of Synthetic Muropeptides to Synergize with Lipopolysaccharide in Cytokine Induction* , 2004, Journal of Biological Chemistry.

[21]  H. Daniel,et al.  The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology , 2004, Pflügers Archiv.

[22]  B. Monks,et al.  TLR9 signals after translocating from the ER to CpG DNA in the lysosome , 2004, Nature Immunology.

[23]  D. Philpott,et al.  Peptidoglycan Molecular Requirements Allowing Detection by Nod1 and Nod2* , 2003, Journal of Biological Chemistry.

[24]  S. Foster,et al.  An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid , 2003, Nature Immunology.

[25]  J. Bertin,et al.  Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan , 2003, Science.

[26]  P. Rosenstiel,et al.  TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells ☆ ☆☆ ★ ★★ ♢ , 2003 .

[27]  M. Chamaillard,et al.  Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.

[28]  S. Foster,et al.  Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.

[29]  Yasunori Ogura,et al.  Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB Activation* , 2002, The Journal of Biological Chemistry.

[30]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[31]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[32]  D. Markovich,et al.  Expression cloning and functional characterization of the kidney cortex high-affinity proton-coupled peptide transporter. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Romero,et al.  Expression cloning of a mammalian proton-coupled oligopeptide transporter , 1994, Nature.

[34]  N. Phillips,et al.  Tumor Cell Binding and Induction of Endothelial Cell Tumoricidal Activity In Vitro by Muramyl Dipeptide Is Enhanced by Liposomal Encapsulation , 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[35]  E. Lederer Synthetic immunostimulants derived from the bacterial cell wall. , 1980, Journal of medicinal chemistry.

[36]  S. Kusumoto,et al.  Macrophage activation by bacterial cell walls and related synthetic compounds , 1979, Infection and immunity.

[37]  M. Kaksonen,et al.  Cytoskeletal networks and pathways involved in endocytosis. , 2005, Novartis Foundation symposium.

[38]  I. Fidler,et al.  Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes. , 1987, International journal of immunopharmacology.

[39]  I. Fidler,et al.  Liposome encapsulation of muramyl peptides for activation of macrophage cytotoxic properties. , 1986, Methods in enzymology.

[40]  E. Lederer New developments in the field of synthetic muramyl peptides, especially as adjuvants for synthetic vaccines. , 1986, Drugs under experimental and clinical research.

[41]  I. Fidler,et al.  Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide. , 1982, Cancer research.